化合物PGS-IN-1 T10098

Product Introduction
Bioactivity


英文名: PGS-IN-1

描述: PGS-IN-1 (KME-4)是一种前列腺素合成酶抑制剂，IC50=0.28 μM。它也可抑制5-脂肪氧合酶的活性，IC50=1.05 μM。

体外活性: PGS-IN-1 is the trans isomer of the synthesized α-benzulidene-γ-butyrolactone. PGS-IN-1 exhibits potent anti-inflammatory and PGS inhibitory activity with IC50 of 0.28 μM[1]. PGS-IN-1 also shows potent inhibitory activity against 5-lipoxygenase with IC50 of 1.05 μM[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 55 mg/ml (181.87 mM)


关键字: PGS-IN-1 | inhibit | PGSIN1 | Lipoxygenase | Inhibitor | KME4 | Prostaglandin E synthase | PGE synthase | LOX | KME 4 | PGS IN 1

相关产品: (S)-Coriolic acid | Bunaprolast | Pectolinarigenin | FPL 62064 | Zileuton | Ligustroside | S-(+)-Marmesin | PXS-6302 hydrochloride | ZD-2138 | Cirsiliol

相关库: ReFRAME Related Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | GPCR Compound Library | Anti-Obesity Compound Library | Metabolism Compound Library | Bioactive Compound Library

化合物PGS-IN-1 T10098信息由TargetMol中国为您提供，如您想了解更多关于化合物PGS-IN-1 T10098报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途